Biomarin Pharmaceutical Inc (NASDAQ:BMRN) showed up in the 13F filings of 523 institutional investors as of December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| BlackRock, Inc. | 31 Dec, 2025 | 0 | -2,910,942 | -13.20% | $0.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 0 | -454,738 | -2.45% | $0.00 |
| Vestal Point Capital, LP | 31 Dec, 2025 | 0 | 2,170,000 | 261.45% | $0.00 |
| HSBC HOLDINGS PLC | 31 Dec, 2025 | 0 | 721,991 | 257.85% | $0.00 |
| DODGE & COX | 31 Dec, 2025 | 0 | -114,417 | -0.78% | $0.00 |
| Deep Track Capital, LP | 31 Dec, 2025 | 0 | 2,275,144 | 9,153.30% | $0.00 |
| Rockefeller Capital Management L.P. | 31 Dec, 2025 | 0 | 366,614 | 102.83% | $0.00 |
| PRIMECAP MANAGEMENT CO/CA/ | 31 Dec, 2025 | 0 | -679,973 | -4.46% | $0.00 |
| UBS Group AG | 31 Dec, 2025 | 0 | 671,551 | 43.60% | $0.00 |
| Barclays Plc | 31 Dec, 2025 | 0 | -853,632 | -74.74% | $0.00 |
| NORGES BANK | 31 Dec, 2025 | 0 | 7,531,080 | 0.00% | $0.00 |
| Squarepoint Ops LLC | 31 Dec, 2025 | 0 | 439,820 | 31.68% | $0.00 |
| State Street Corp | 31 Dec, 2025 | 0 | -1,241,381 | -14.16% | $0.00 |
| Qube Research & Technologies Ltd | 31 Dec, 2025 | 0 | 1,176,410 | 452.07% | $0.00 |
| AQR CAPITAL MANAGEMENT LLC | 31 Dec, 2025 | 0 | 754,807 | 12.72% | $0.00 |
| Soleus Capital Management, L.P. | 31 Dec, 2025 | 0 | 429,696 | 48.26% | $0.00 |
| VIKING GLOBAL INVESTORS LP | 31 Dec, 2025 | 0 | -2,285,243 | -27.46% | $0.00 |
| Pictet Asset Management Holding SA | 31 Dec, 2025 | 0 | 393,409 | 44.19% | $0.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 0 | 131,969 | 3.73% | $0.00 |
| Pacer Advisors, Inc. | 31 Dec, 2025 | 0 | 327,204 | 53.63% | $0.00 |